Tumor immunotherapy has rapidly emerged as a cornerstone in oncology, revolutionizing the treatment landscape for patients with advanced malignancies.

BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...

Researchers at the University of Southampton have developed a new antibody design that boosts the immune system’s ability to fight cancer by enhancing activation of T cells through the CD27 receptor.

Immunotherapy in particular, she said, could mean the difference between relapse and survival. Kiu said SCCS supported ...

New York, United States, January 7th, 2026, FinanceWireGlobal investment management leader Aurum Capital has announced the ...

Elephas Biosciences Corporation (Elephas), a privately held leader in precision oncology, today announced the publication of a foundational paper in Journal of Translational Medicine. The paper ...

Fred Hutch researchers launch free online tool to assess colorectal cancer risk Researchers led by Ulrike “Riki” Peters, PhD, MPH, holder of the 40th Anniversary Endowed Chair, and Li Hsu, PhD, ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, al ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...

Dr Benjamin George transforms oncology care in rural Nebraska, addressing unique challenges and enhancing access to vital ...

In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...